 |
|
|
| |
Superior Efficacy of Dolutegravir/Abacavir/Lamivudine FDC Compared With Ritonavir-Boosted Atazanavir Plus Tenofovir Disoproxil Fumarate/Emtricitabine FDC in Treatment-Naive Women With HIV-1 Infection: ARIA Study
|
| |
| |
Reported by Jules Levin
Durban 2016 July 18-22
C. Orrell,1 D. Hagins,2 E. Belonosova,3 N. Porteiro,4 S. Walmsley,5 V. Falcó,6 C. Man,7 A. Aylott,8 A. Buchanan,7 B. Wynne,9 C. Vavro,7 M. Aboud,10 K. Smith7
1Desmond Tutu HIV Foundation, Cape Town, South Africa; 2Chatham County Health Department, Savannah, GA, USA; 3Orel Regional Center for AIDS, Orel, Russia; 4Fundación IDEAA, Buenos Aires, Argentina; 5University Health Network, Toronto, Canada; 6Hospital Vall d’Hebron, Barcelona, Spain; 7,9,10ViiV Healthcare, 7Research Triangle Park, NC, USA; 9Philadelphia, PA, USA; 10 Brentford, UK; 8GlaxoSmithKline Stockley Park, UK
|
| |
|
|
|
|
|
